Sort   by:  
 Page size 
UnknownA retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases.
Not available
S-EPMC12559634 | biostudies-literature
UnknownTargeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.
Not available
S-EPMC4409566 | biostudies-literature
UnknownEvolution of AF6-RAS association and its implications in mixed-lineage leukemia.
Not available
S-EPMC5653649 | biostudies-literature
ProteomicsSupporting MS data for paper (doi:10.1038/s41565-025-02080-2) by Goerzen, D. et al (2025), titled "Machine perception liquid biopsy identifies brain tumours via systemic immune and tumour microenvironment signature"
Supporting MS data for paper (doi:10.1038/s41565-025-02080-2) by Goerzen, D. et al (2025), titled "Machine perception liquid biopsy identifies brain tumors via systemic immune and tumor microenvironment signature." The index of experiments, related MS files, and labels is provided in the uploaded Ex...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2025-10-13 | MSV000099468 | MassIVE
UnknownMultiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
Not available
S-EPMC9041819 | biostudies-literature
GenomicsGlioma GWAS summary statistics
Meta-analysis association statistics from case-control analysis (includes imputed SNPs)
EGAD00010001657 | EGA
GenomicsSummary statistics from genome-wide association study in glioma of 12,488 cases and 18,169 controls.
Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, but individual studies have had limited power to identify risk loci. We performed a meta-analysis of existing GWAS and two new GWAS, which totaled 12,488 cases and 18,169 controls. We identified five ...
EGAS00001003372 | EGA
GenomicsGlioma GWAS summary statistics DAC
Data Access Committee EGAC00001001116
EGAC00001001116 | EGA
UnknownAnti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial.
Not available
S-EPMC10540058 | biostudies-literature
UnknownA Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic Architecture.
Not available
S-EPMC12873861 | biostudies-literature
Sort   by:  
 Page size